Objective: The aim of this study was to investigate the impact of adrenal hyperandrogenism on insulin resistance and lipid profile in women with polycystic ovary syndrome (PCOS).
Patients And Methods: We studied 372 women with PCOS according to the NIH criteria. 232 age- and BMI-matched women served as controls in order to define adrenal hyperandrogenism (DHEA-S >95th percentile). Then, patients with PCOS were classified into two groups: with adrenal hyperandrogenism (PCOS-AH, = 108) and without adrenal hyperandrogenism (PCOS-NAH, = 264). Anthropometric measurements were recorded. Fasting plasma glucose, insulin, lipid profile, sex hormone-binding globulin (SHBG) and androgen (TT, Δ4A, DHEA-S) concentrations were assessed. Free androgen index (FAI) and homeostatic model assessment-insulin resistance (HOMA-IR) index were calculated.
Results: Women with PCOS-AH were younger than PCOS-NAH ( < 0.001), but did not differ in the degree and type of obesity. No differences were found in HOMA-IR, total cholesterol, HDL-c, LDL-c and triglyceride concentrations (in all comparisons, > 0.05). These metabolic parameters did not differ between the two groups even after correction for age. Women with PCOS-AH had lower SHBG (29.2 ± 13.8 vs 32.4 ± 11.8 nmol/L, = 0.025) and higher TT (1.0 ± 0.2 vs 0.8 ± 0.4 ng/mL, = 0.05) and Δ4A (3.9 ± 1.2 vs 3.4 ± 1.0 ng/mL, = 0.007) concentrations, as well as FAI (14.1 ± 8.0 vs 10.2 ± 5.0, < 0.001). These results were confirmed by a multiple regression analysis model in which adrenal hyperandrogenism was negatively associated with age ( < 0.001) and SHBG concentrations ( = 0.02), but not with any metabolic parameter.
Conclusions: Women with PCOS and adrenal hyperandrogenism do not exhibit any deterioration in insulin resistance and lipid profile despite the higher degree of total androgens.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640571 | PMC |
http://dx.doi.org/10.1530/EC-17-0239 | DOI Listing |
Transgend Health
December 2024
University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
Purpose: This study aims to assess the prevalence of intersex variations/differences in sex development (I/DSDs), associated adrenal conditions, and primary gonadal insufficiency in children with gender dysphoria.
Methods: We performed a comprehensive review of the medical records for individuals who carried the diagnostic codes for gender dysphoria in addition to intersex and/or other conditions associated with sex steroid variations among patients evaluated by pediatric endocrinologists from 2013 to 2022.
Results: We found that 9 of 612 (1.
J Ayub Med Coll Abbottabad
November 2024
Faisalabad Medical University, Faisalabad-Pakistan.
Post Reprod Health
November 2024
Obstetrics and Gynecology Unit, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.
A woman in her 70s presented with features of hyperandrogenism including clitoral enlargement and deepening of her voice. Biochemical investigations revealed raised plasma androgens and urinary androgen metabolites and imaging findings showed a highly F-18 fluorodeoxyglucose (FDG)-PET avid left adrenal tumour initially suspected to be a malignant adrenocortical carcinoma (ACC). She subsequently underwent an uncomplicated laparoscopic adrenalectomy where complete resection of her tumour was achieved.
View Article and Find Full Text PDFJCEM Case Rep
December 2024
Department of Pathology, Queen Elizabeth Hospital, Hong Kong, P. R. China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!